Urgent.News

What's breaking now, across thousands of outlets.

Science

STAT+: Roivant lung disease drug hits mid-stage study goals

These positive results could open up a new way to treat serious lung disease.

STAT+: Roivant lung disease drug hits mid-stage study goals

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at statnews.com →

More in Science

More from Tuesday 8 September →